Klarna announced a major milestone in its U.S. growth strategy on Tuesday, revealing a deal to sell up to $6.5 billion in loans over the next two years to funds managed by Elliott Investment Management. The partnership marks one of the Swedish fintech’s largest forward-flow agreements to date as it doubles down on its fast-growing...
Activist Fund Enkraft Calls for Fair M&A Process at ABO Energy Amid Control Shift Concerns
A new development in Germany’s renewable energy sector has emerged as activist fund Enkraft urges ABO Energy to ensure that its ongoing sales process protects all shareholders, not only the founding families who currently hold 52% of the company. The call comes after ABO Energy announced in late September that it had appointed private bank...
J&J Accelerates Its Oncology Expansion With a $3.05 Billion Acquisition of Halda Therapeutics
Johnson & Johnson has announced a bold strategic move with the $3.05 billion cash acquisition of Halda Therapeutics, reinforcing its rapid push into high-growth oncology markets. This marks J&J’s second major deal of the year, following its $14.6 billion takeover of Intra-Cellular Therapies in January, and continues a strong M&A trajectory that includes its $13.1...
HoloSolis Secures $255 Million to Build One of Europe’s Largest Solar Panel Factories
French clean-energy company HoloSolis has raised over €220 million ($255 million) to accelerate the construction of a major solar panel manufacturing plant in Sarreguemines-Hambach, a project set to become one of Europe’s largest and most strategic renewable-energy facilities. Why it matters The investment arrives at a crucial moment for Europe. Solar energy is central to...
Alphabet Hits Record High After Berkshire’s $4.9B Vote of Confidence
Alphabet shares surged nearly 6% to a new record after Berkshire Hathaway revealed a $4.93 billion stake — a rare tech bet from a historically tech-averse conglomerate. The move signals strong conviction in Alphabet’s AI strategy, even as the market grows increasingly cautious about stretched valuations and massive data-center spending across Big Tech. 🔍 Key...
Siemens Healthineers Signals Potential Diagnostics Spin-Off by 2030
Siemens Healthineers is exploring a possible divestment or spin-off of its Diagnostics division by 2030, as the company reshapes its portfolio and refocuses long-term growth. CEO Bernd Montag said the business may no longer remain part of Healthineers if independence is deemed the better strategic path. No discussions with potential buyers have started yet. 📊...
